Correlation Between VistaGen Therapeutics and Oncternal Therapeutics

Can any of the company-specific risk be diversified away by investing in both VistaGen Therapeutics and Oncternal Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining VistaGen Therapeutics and Oncternal Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between VistaGen Therapeutics and Oncternal Therapeutics, you can compare the effects of market volatilities on VistaGen Therapeutics and Oncternal Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in VistaGen Therapeutics with a short position of Oncternal Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of VistaGen Therapeutics and Oncternal Therapeutics.

Diversification Opportunities for VistaGen Therapeutics and Oncternal Therapeutics

0.0

Correlation Coefficient

VistaGen Therapeutics  Oncternal Therapeutics

Pay attention - limited upside

The 3 months correlation between VistaGen and Oncternal is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding VistaGen Therapeutics and Oncternal Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oncternal Therapeutics and VistaGen Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on VistaGen Therapeutics are associated (or correlated) with Oncternal Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oncternal Therapeutics has no effect on the direction of VistaGen Therapeutics i.e., VistaGen Therapeutics and Oncternal Therapeutics go up and down completely randomly.

Pair Corralation between VistaGen Therapeutics and Oncternal Therapeutics

If you would invest (100.00) in Oncternal Therapeutics on December 30, 2024 and sell it today you would earn a total of  100.00  from holding Oncternal Therapeutics or generate -100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

VistaGen Therapeutics  vs.  Oncternal Therapeutics

VistaGen Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days VistaGen Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, VistaGen Therapeutics is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Oncternal Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Oncternal Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, Oncternal Therapeutics is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with VistaGen Therapeutics and Oncternal Therapeutics

The main advantage of trading using opposite VistaGen Therapeutics and Oncternal Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if VistaGen Therapeutics position performs unexpectedly, Oncternal Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oncternal Therapeutics will offset losses from the drop in Oncternal Therapeutics' long position.

The idea behind VistaGen Therapeutics and Oncternal Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.